Terminated PHASE2 INTERVENTIONAL NCT00366106

Alternative Schedule of Velcade/Dexamethasone Plus Doxil for Patients With Multiple Myeloma

A Phase II, Open Label Study Evaluating an Alternative Schedule of Velcade/Dexamethasone Plus Doxil in the Treatment of Multiple Myeloma

Sponsor: Accelerated Community Oncology Research Network

Conditions Multiple Myeloma

Interventions bortezomib dexamethasone doxorubicin HCl liposome

Updated 12 times since 2017 Last updated: Apr 4, 2012 Started: Jul 31, 2006 Primary completion: Mar 31, 2011 Completion: Mar 31, 2011

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Study was closed to enrollment when it became clear that enrollment was too slow to complete full enrollment target within time frame allowed.

Other terminated trials from Accelerated Community Oncology Research Network

See all terminations from Accelerated Community Oncology Research Network

Other Multiple Myeloma trials with similar outcome

Browse all Multiple Myeloma trials

A PHASE2 clinical study on Multiple Myeloma, this trial is terminated or withdrawn. The trial is conducted by Accelerated Community Oncology Research Network and has accumulated 12 data snapshots since 2006. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

12 versions recorded

Sep 2024 — Present [monthly]

Terminated PHASE2
Jul 2024 — Sep 2024 [monthly]

Terminated PHASE2
Jan 2023 — Jul 2024 [monthly]

Terminated PHASE2
Dec 2022 — Jan 2023 [monthly]

Terminated PHASE2
Dec 2021 — Dec 2022 [monthly]

Terminated PHASE2

▶ Show 7 earlier versions

Jan 2021 — Dec 2021 [monthly]

Terminated PHASE2
Nov 2020 — Jan 2021 [monthly]

Terminated PHASE2
Jun 2018 — Nov 2020 [monthly]

Terminated PHASE2
May 2018 — Jun 2018 [monthly]

Terminated PHASE2
Aug 2017 — May 2018 [monthly]

Terminated PHASE2
Feb 2017 — Aug 2017 [monthly]

Terminated PHASE2
Jan 2017 — Feb 2017 [monthly]

Terminated PHASE2

First recorded

Jul 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Accelerated Community Oncology Research Network
Millennium Pharmaceuticals, Inc.

Data source: Accelerated Community Oncology Research Network

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Athens, United States , Augusta, United States , Billings, United States , Canton, United States , Chesapeake, United States , Clinton, United States , Coeur d'Alene, United States , Columbus, United States , La Verne, United States , Lake Success, United States and 5 more locations